Indication
In combination with cisplatin and gemcitabine, for the first-line treatment of adult patients with recurrent, not amenable to surgery or radiotherapy, or metastatic nasopharyngeal carcinoma.
Medicine details
- Medicine name:
- toripalimab (Loqtorzi)
- SMC ID:
- SMC2983
- Pharmaceutical company
- LEO Pharma
- BNF chapter
- Malignant disease and immunosuppression
- Submission type
- Full
- Publication due date:
- TBC
- SMC meeting date:
- TBC
- Patient group submission deadline:
- TBC